SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-210939
Filing Date
2019-08-01
Accepted
2019-08-01 16:32:32
Documents
4
Period of Report
2019-07-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d748479d8k.htm 8-K 18127
2 EX-99.1 d748479dex991.htm EX-99.1 82041
3 EX-99.2 d748479dex992.htm EX-99.2 44652
4 GRAPHIC g748479g09u61.jpg GRAPHIC 9047
  Complete submission text file 0001193125-19-210939.txt   158525
Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Filer) CIK: 0001492674 (see all company filings)

IRS No.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36571 | Film No.: 19993143
SIC: 3841 Surgical & Medical Instruments & Apparatus